| Recurrent Thrombotic Events after Catastrophic Antiphopholipid Syndrome |
|
Park, Hayne-Cho
(Department of Internal Medicine, Seoul National University Hospital)
Yoon, Hyun-Bae (Department of Internal Medicine, Seoul National University Hospital) Lee, Tae-Woo (Department of Internal Medicine, Seoul National University Hospital) Jung, Ji-Yong (Department of Internal Medicine, Seoul National University Hospital) Chin, Ho-Jun (Renal Research Institute, Seoul National University College of Medicine) Kim, Yon-Su (Department of Internal Medicine, Seoul National University Hospital) Kim, Suhng-Gwon (Department of Internal Medicine, Seoul National University Hospital) |
| 1 | Asherson RA, Cervera R, de Groot PG, et al. Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines. Lupus 2003;12:530-534. DOI ScienceOn |
| 2 | Erkan D. Therapeutic and prognostic considerations in catastrophic antiphospholipid syndrome. Autoimmun Rev 2006;6:98-103. DOI ScienceOn |
| 3 | Cervera R, Piette JC, Font J, et al. Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum 2002;46:1019-1027. DOI ScienceOn |
| 4 | Bucciarelli S, Espinosa G, Cervera R, et al. Mortality in the catastrophic antiphospholipid syndrome: causes of death and prognostic factors in a series of 250 patients. Arthritis Rheum 2006;54:2568-2576. DOI ScienceOn |
| 5 | Espinosa G, Bucciarelli S, Asherson RA, Cervera R. Morbidity and mortality in the catastrophic antiphospholipid syndrome: pathophysiology, causes of death, and prognostic factors. Semin Thromb Hemost 2008;34:290-294. DOI ScienceOn |
 |
Korea Institute of Science and Technology Information
Gwahangno, Yuseong-gu, Daejeon, 305-806, Korea TEL : +82-42-869-1752
Copyright (c) 2009 KISTI. All Rights Reserved. For more information mail to
webmaster
